Simulated regional mean wetland seasons. by Nic Gedney (19762301)

Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

“…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”

Z-stack showing <i>N</i>. <i>bombycis</i> infection in the nurse cells and oocytes at the vitellogenesis stage on the fifth day of pupation. by Chunxia Wang (766713)

Subjects:

Z-stack showing <i>N</i>. <i>bombycis</i> adhering to the surface of the ovariole aat the previtellogenesis stage on the fifth day of pupation. by Chunxia Wang (766713)

Subjects:

Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”

Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”

Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”

Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”

Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”

Results of SD-TOPSIS application ‐ combinations B1-B5. by Roman Vavrek (13200141)

<b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b> by Samuel Briggs-Price (17735046)

Model diagnostics for all death events. by Xin Zhang (35492)

“…At the MMT of 23.5°C, the cumulative relative risk (cumRR) for mortality within a lag period of 0–14 days from the highest temperature (31°C) was estimated at 2.114 (95% confidence interval [CI]: 1.475 ~ 3.028). …”

Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. by Garett Dunsmore (11021169)

Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation. by Cynthia Alsayyah (18452506)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

The rate the bias decreases with sample duration is higher for cells with higher activity levels. by Liron Sheintuch (12078310)

Oral infection with YFV-Asibi cap0 leads to lower viral loads in the midguts largely diminishing dissemination to secondary tissues. by Anja vom Hemdt (19787189)

Subjects:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for BP() and NB() under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

NbNBR1 decreases the ubiquitination level of total protein after TYLCCNV/TYLCCNB infection. by Tingting Zhou (163678)

Activation is greater for youth in the before prize condition (<i>n</i> = 226) vs. after prize condition (<i>n</i> = 220) during large win > small win trials in the MTwiNS sample (... by Melissa K. Peckins (12042132)